ArticleThe Lancet. Haematology2019

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.

Jacob D Soumerai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.